PTSD.post-traumatic stress disorder

Psychedelics

By Lorimer WilsonPosted September 6, 2024Tags: 3, 4-methylenedioxymethamphetamine, anorexia nervosa, attention deficit hyperactivity disorder, autism spectrum disorder, DMT, generalized anxiety disorder, mebufotenin, neurological disorders, postpartum depression, psilocybin therapy, psychiatric disorders, PTSD.post-traumatic stress disorder, social anxiety disorder, treatment-resistant depression

Psychedelic Compound Drug Stocks Portfolio DOWN w/e Sept. 6th

An Introduction While the psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come, the stocks of the companies involved are having growing pains. Some Background Shares of clinical-stage companies developing treatments based on psychedelic compound-based...